Log in to save to my catalogue

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD r...

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD r...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_26daa0d3187e4841a7a7fa420c1cad83

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings

About this item

Full title

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings

Publisher

England: BioMed Central

Journal title

Alzheimer's research & therapy, 2020-01, Vol.12 (1), p.8-8, Article 8

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Recruitment is often a bottleneck in secondary prevention trials in Alzheimer disease (AD). Furthermore, screen-failure rates in these trials are typically high due to relatively low prevalence of AD pathology in individuals without dementia, especially among cognitively unimpaired. Prescreening on AD risk factors may facilitate recruitment, but th...

Alternative Titles

Full title

Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_26daa0d3187e4841a7a7fa420c1cad83

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_26daa0d3187e4841a7a7fa420c1cad83

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-019-0576-y

How to access this item